Healthcare provider profile · identity verified

Dana Chase Ducote, MD

Family Practice · BIGFORK, MT · NPI 1922060037

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	346	83
Amlodipine Besylate	Amlodipine Besylate	228	56
Rosuvastatin Calcium	Rosuvastatin Calcium	181	53
Lorazepam	Lorazepam	174	29
Gabapentin	Gabapentin	169	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	167	30
Omeprazole	Omeprazole	161	46
Zolpidem Tartrate	Zolpidem Tartrate	160	40
Losartan Potassium	Losartan Potassium	144	41
Lisinopril	Lisinopril	135	37
Tramadol Hcl	Tramadol Hcl	126	25
Metformin Hcl	Metformin Hcl	107	28
Atorvastatin Calcium	Atorvastatin Calcium	106	34
Pravastatin Sodium	Pravastatin Sodium	106	25
Hydrochlorothiazide	Hydrochlorothiazide	104	30
Duloxetine Hcl	Duloxetine Hcl	103	20
Alprazolam	Alprazolam	101	18
Meloxicam	Meloxicam	101	29
Escitalopram Oxalate	Escitalopram Oxalate	89	17
Metoprolol Succinate	Metoprolol Succinate	89	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	78	14
Pantoprazole Sodium	Pantoprazole Sodium	77	24
Trazodone Hcl	Trazodone Hcl	73	17
Sertraline Hcl	Sertraline Hcl	72	20
Spironolactone	Spironolactone	72	16
Tizanidine Hcl	Tizanidine Hcl	71	20
Eliquis	Apixaban	67	11
Propranolol Hcl	Propranolol Hcl	58	15
Furosemide	Furosemide	57	20
Clopidogrel	Clopidogrel Bisulfate	55	14
Celecoxib	Celecoxib	54	21
Tamsulosin Hcl	Tamsulosin Hcl	53	14
Memantine Hcl	Memantine Hcl	52	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	52	16
Simvastatin	Simvastatin	51	15
Fluoxetine Hcl	Fluoxetine Hcl	49	17
Ezetimibe	Ezetimibe	46	11
Estradiol	Estradiol	45	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	12
Citalopram Hbr	Citalopram Hydrobromide	44	12
Albuterol Sulfate Hfa	Albuterol Sulfate	41	28
Carvedilol	Carvedilol	39	suppressed
Benazepril Hcl	Benazepril Hcl	38	suppressed
Ibandronate Sodium	Ibandronate Sodium	38	12
Montelukast Sodium	Montelukast Sodium	38	suppressed
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Xarelto	Rivaroxaban	38	suppressed
Potassium Chloride	Potassium Chloride	37	12
Pregabalin	Pregabalin	34	suppressed
Valacyclovir	Valacyclovir Hcl	32	13
Armour Thyroid	Thyroid,pork	30	suppressed
Atenolol	Atenolol	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Morphine Sulfate	Morphine Sulfate	29	suppressed
Raloxifene Hcl	Raloxifene Hcl	28	suppressed
Acyclovir	Acyclovir	27	suppressed
Allopurinol	Allopurinol	27	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Jardiance	Empagliflozin	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Eszopiclone	Eszopiclone	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Cephalexin	Cephalexin	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	19
Torsemide	Torsemide	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Prednisone	Prednisone	22	13
Rizatriptan	Rizatriptan Benzoate	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Lovastatin	Lovastatin	20	suppressed
Bupropion Hcl	Bupropion Hcl	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Azithromycin	Azithromycin	18	16
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	17	suppressed
Flecainide Acetate	Flecainide Acetate	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Diazepam	Diazepam	15	suppressed
Valsartan	Valsartan	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Famotidine	Famotidine	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Premarin	Estrogens, Conjugated	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Estradiol (Once Weekly)	Estradiol	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Nexium	Esomeprazole Magnesium	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Neomycin Sulfate	Neomycin Sulfate	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Topiramate	Topiramate	12	suppressed
Cevimeline Hcl	Cevimeline Hcl	11	suppressed
Finasteride	Finasteride	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Temazepam	Temazepam	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Xopenex Hfa	Levalbuterol Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error